Professional Design Otc Antiseptic - Procaine suppliers in china with cas 59-46-1 – Guanlang Detail:
Hebei Guanlang Biotechnology Co., Ltd. is one of the leading procaine suppliers in china, we produce procaine from our own factory and our own technology mainly for customers from europe and america.
Procaine Basic Info.
CAS: 59-46-1
MF: C13H20N2O2
MW: 236.31
EINECS: 200-426-9
Chemical properties : white crystal.
Usage inhibitor of sodium channel. Local anesthetics.
The toxicity effect of humble, rapid and safe. Suitable for local anesthesia, applied to the eye, ear, nose, teeth, operation, used for infiltration anesthesia, anesthesia and closed therapy supervisor. The product is also used in the production of procaine penicillin.
Product detail pictures:
Related Product Guide:
Cooperation
We always think and practice corresponding to the change of circumstance, and grow up. We aim at the achievement of a richer mind and body and the living for Professional Design Otc Antiseptic - Procaine suppliers in china with cas 59-46-1 – Guanlang, The product will supply to all over the world, such as: Iraq, Bangladesh, Jamaica, To meet the requirements of specific customers for each bit more perfect service and stable quality merchandise. We warmly welcome customers around the world to visit us, with our multi-faceted cooperation, and jointly develop new markets, create a brilliant future!
Hebei Guanlang Biotechnology Co., Ltd. belongs to Guanlang Group, which was founded in 2007 , located in Shijiazhuang city which is the capital of Hebei Province and hub sector among Beijing Tianjin and Hebei and has advantage of convenient transportation . Our company is a modern high-tech chemical enterprise with Research & Development, production and sales.We have our own factory and lab,also offer customized synthesis service for our customers.
By Joanna from New Delhi - 2018.03.03 13:09
It is really lucky to meet such a good supplier, this is our most satisfied cooperation, I think we will work again!
By Rosemary from Nicaragua - 2018.02.12 14:52